| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/25/2001 | CA2379058A1 Pseudomycin prodrugs |
| 01/25/2001 | CA2379022A1 Cyclic peptide derivatives as inhibitors of integrin .alpha.v.beta.6 |
| 01/25/2001 | CA2378954A1 The il-1l1 gene and polypeptide products |
| 01/25/2001 | CA2378946A1 Psca: prostate stem cell antigen and uses thereof |
| 01/25/2001 | CA2378930A1 Electron transfer proteins |
| 01/25/2001 | CA2378917A1 Melanin-concentrating hormone receptor |
| 01/25/2001 | CA2378868A1 Process for deacylation of lipodepsipeptides |
| 01/25/2001 | CA2378249A1 Use of fviia or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis |
| 01/25/2001 | CA2378026A1 Novel glycosyl sulfotransferases gst-4.alpha., gst-4.beta., and gst-6 |
| 01/25/2001 | CA2377937A1 Oligoneucleotides for metabotropic glutamate receptor type 1 (mglur1) |
| 01/25/2001 | CA2377247A1 Activation and protection of cytotoxic lymphocytes using a reactive oxygen metabolite inhibitor |
| 01/25/2001 | CA2376641A1 Chimeric polypeptides of serum albumin and uses related thereto |
| 01/25/2001 | CA2375943A1 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 01/25/2001 | CA2375467A1 Antisense therapy for hormone-regulated tumors |
| 01/25/2001 | CA2375458A1 Compositions and methods for the treatment of immune related diseases |
| 01/25/2001 | CA2340721A1 Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor |
| 01/24/2001 | EP1070758A1 Novel protein and processes for producing the same |
| 01/24/2001 | EP1070727A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 01/24/2001 | EP1070504A1 Materials for preventing arteriosclerosis, immunopotentiating materials, vertebrates fed with these materials and eggs thereof |
| 01/24/2001 | EP1070143A2 Glaucoma therapeutics and diagnostics |
| 01/24/2001 | EP1070141A1 Immediate early genes and methods of use therefor |
| 01/24/2001 | EP1070133A2 Biological material with increased expression of endogenous complement regulatory molecules |
| 01/24/2001 | EP1070131A1 Ubiquitin conjugating enzyme |
| 01/24/2001 | EP1070129A2 Dadd, death activator death domain protein |
| 01/24/2001 | EP1070125A2 Human nucleic acid sequences from normal breast tissue |
| 01/24/2001 | EP1070124A1 Secreted proteins and polynucleotides encoding them |
| 01/24/2001 | EP1070123A2 Herpes simplex virus latency associated transcript polypeptides |
| 01/24/2001 | EP1070122A2 Induction of apoptic or cytotoxic gene expression by adenoviral mediated gene codelivery |
| 01/24/2001 | EP1070121A1 The cytokine family member ef-7 |
| 01/24/2001 | EP1070118A1 Modified adenovirus containing a fiber replacement protein |
| 01/24/2001 | EP1070085A1 DUAL A v?b 3? AND METASTASIS-ASSOCIATED RECEPTOR LIGANDS |
| 01/24/2001 | EP1070084A1 PIPERAZINES AS INHIBITORS OF FRUCTOSE-1,6-BISPHOSPHATASE (FBPase) |
| 01/24/2001 | EP1070083A1 Crystalline forms of 1s- 1alpha (2s*,3r*), 9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9- (1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino 1, 2-a] 1,2] diazepin- 1-carboxamide |
| 01/24/2001 | EP1070064A1 Antagonists of gonadotropin releasing hormone |
| 01/24/2001 | EP1070060A1 Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists |
| 01/24/2001 | EP1070047A2 Lipids |
| 01/24/2001 | EP1069917A1 Novel complementing receptor-ligand pairs and adoptive immunotherapy using same |
| 01/24/2001 | EP1069912A1 Injectable igf-formulations containing succinate as buffering agent |
| 01/24/2001 | EP1069909A2 Conjugate vaccines for the prevention of dental caries |
| 01/24/2001 | EP1069907A1 DIAGNOSIS, PREVENTION AND TREATMENT OF ULCERATIVE COLITIS, AND CLINICAL SUBTYPES THEREOF, USING MICROBIAL UC pANCA ANTIGENS |
| 01/24/2001 | EP1069906A1 Conjugates useful in the treatment of prostrate cancer |
| 01/24/2001 | EP1069905A1 Method and composition for lowering low density lipoprotein cholesterol |
| 01/24/2001 | EP1069890A1 Incorporation of active substances in carrier matrixes |
| 01/24/2001 | EP1069887A1 Aerosol composition |
| 01/24/2001 | EP0868192A4 Fast drying, film forming iodine release solution |
| 01/24/2001 | EP0788513B1 Use of binding agents to cd23 in the treatment of autoimmune diseases |
| 01/24/2001 | EP0712389B1 Therapeutic compound - fatty acid conjugates |
| 01/24/2001 | EP0694039B1 1,5-benzodiazepine derivatives having cck antagonistic and or agonistic activity |
| 01/24/2001 | EP0676964B1 Nitrosylation of enzyme sh groups as a therapeutic modality |
| 01/24/2001 | EP0630260B1 Polysaccharide-protein conjugates |
| 01/24/2001 | EP0557498B1 Bone-growth-stimulating composition |
| 01/24/2001 | CN1281509A Human MDG1 gene (CBFAWB10) |
| 01/24/2001 | CN1281468A Treatment with anti-ErbB2 antibodies |
| 01/24/2001 | CN1281466A Aggregates of human insulin derivatives |
| 01/24/2001 | CN1281463A Human PTD 010 gene (TPAAAG12) |
| 01/24/2001 | CN1281370A Stabilized teriparatide solutions |
| 01/24/2001 | CN1281369A Glucagon-like peptide-1 crystals |
| 01/24/2001 | CN1281368A Oromucosal cytokine compositions and uses thereof |
| 01/24/2001 | CN1281367A Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 01/24/2001 | CN1281366A Prevention and treatment of amyloidogenic disease |
| 01/24/2001 | CN1281365A Composition and method for increasing insulin activity |
| 01/24/2001 | CN1281336A Treatment of neoplasms with viruses |
| 01/24/2001 | CN1280985A Recombined human hopatocyte auxin, its preparing process and its clinical application |
| 01/24/2001 | CN1280857A Medicinal composition for treating thyroidism |
| 01/24/2001 | CN1280856A Composition of stable bioactive substances and its preparing process |
| 01/24/2001 | CN1280855A Medicinal composition containing algal protein polyose extract and extraction of algal protein polyose |
| 01/24/2001 | CN1061095C Process for preparing glycopeptide antibiotics |
| 01/24/2001 | CN1061087C Strawberry wine and its producing method |
| 01/23/2001 | US6177556 Nucleotide sequences coding stem cell factor protein; for use in in vitro fertilization therapy |
| 01/23/2001 | US6177550 Process for extraction of a growth factor complex |
| 01/23/2001 | US6177549 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof |
| 01/23/2001 | US6177547 The specified glycoprotein ligand comprising a fucosylated sialylated glycoprotein containing sialyl lewis x antigen; antibody has binding specific for p-selectin glycoprotein ligand; use modifying inflammatory process, diagnostic assays |
| 01/23/2001 | US6177546 Human glutathione-S-transferase |
| 01/23/2001 | US6177545 Antibody which preferentially binds an epitope of an enzymatic protein; for diagnosis of time events in tumor propagation and metastasis, autoimmune diseases, kidney defects and atherosclerotic injury |
| 01/23/2001 | US6177544 Collagen-based auxiliary agent for ophthalmic surgery |
| 01/23/2001 | US6177543 Homogeneous human lymphokines; for the treatment of tumors; antitumor agents |
| 01/23/2001 | US6177542 Amino acid sequence which activates cell attachment; for utilization as a wound healing agent, tissue maintenance and prevention of tumor propagation; antitumor agents |
| 01/23/2001 | US6177478 Using an amine polymer; prevent kidney stones |
| 01/23/2001 | US6177475 Methods of using integrin modulators for treatment of inflammation |
| 01/23/2001 | US6177468 Modulation of inflammation related to columnar epithelia |
| 01/23/2001 | US6177467 Tumor necrosis factor antagonist |
| 01/23/2001 | US6177428 Treatment of sexual dysfunction; stimulation of endogenous nitrogen monoxide synthesis |
| 01/23/2001 | US6177407 Specifically ischemic cardiac tissue, by administering at least one of angiotensinogen and specified sequences encoding angiotensin i, its analogues and fragments, angiotensin ii (aii) analogues or fragments, and aii at2 type 2 receptor |
| 01/23/2001 | US6177406 Isolated bone morphogenetic protein-3 (bmp-3) comprising specified amino acid sequence(s); administering to induce formation of chondrocyte and/or cartilage tissue in a patient |
| 01/23/2001 | US6177405 Cyclic analogs of tuftsin |
| 01/23/2001 | US6177403 Compositions, methods, and apparatus for delivery of a macromolecular assembly to an extravascular tissue of an animal |
| 01/23/2001 | US6177402 Promoting survival of mammalian sensory neurons by contacting with leukemia inhibitory factor (lif) |
| 01/23/2001 | US6177401 Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis |
| 01/23/2001 | US6177272 Method for treating vascular proliferative diseases with p27 and fusions thereof |
| 01/23/2001 | US6177258 Amino acid sequences of protein; for screening enzyme inhibitors for use as parasiticides/insecticides; veterinary medicine |
| 01/23/2001 | US6177257 Immunoassay diagnosis of susceptibility to atherosclerosis by analyzing blood for presence of enzyme using polyclonal or monoclonal antibodies; elevated levels are indicative of susceptibility |
| 01/23/2001 | US6177253 Screening methods for the identification of anti-HIV compounds employing a cyclosporine-specific monoclonal antibody that cross-reacts with HIV-1 p24 |
| 01/23/2001 | US6177245 Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms |
| 01/23/2001 | US6177244 Oligonucleotide which hybridizes to nucleic acid of defined nucleotide sequence; diagnosis; drug screening; antitumor agents; antimetastasis agents |
| 01/23/2001 | US6177103 Processes to generate submicron particles of water-insoluble compounds |
| 01/23/2001 | US6177087 Administering a polymer conjugate |
| 01/23/2001 | US6177086 DNA molecule conferring on Mycobacterium tuberculosis resistance against antimicrobial reactive oxygen and nitrogen intermediates |
| 01/23/2001 | US6177080 Polypeptides encoded by Kaposi sarcoma-associated herpes virus the use thereof in diagnosis and therapy |
| 01/23/2001 | US6177079 Monoclonal antibodies against interleukins |
| 01/23/2001 | US6177078 Binding interleukins |